- Home
- CMPX vs ONDS Comparison
CMPX vs ONDS Comparison
Compare CMPX & ONDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- ONDS
- Stock Information
- Founded
- CMPX 2014
- ONDS 2014
- Country
- CMPX United States
- ONDS United States
- Employees
- CMPX N/A
- ONDS N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- ONDS Telecommunications Equipment
- Sector
- CMPX Health Care
- ONDS Telecommunications
- Exchange
- CMPX Nasdaq
- ONDS Nasdaq
- Market Cap
- CMPX 291.8M
- ONDS 326.8M
- IPO Year
- CMPX N/A
- ONDS N/A
- Fundamental
- Price
- CMPX $3.20
- ONDS $2.00
- Analyst Decision
- CMPX Strong Buy
- ONDS Strong Buy
- Analyst Count
- CMPX 9
- ONDS 2
- Target Price
- CMPX $12.67
- ONDS $3.25
- AVG Volume (30 Days)
- CMPX 729.4K
- ONDS 20.1M
- Earning Date
- CMPX 08-11-2025
- ONDS 08-13-2025
- Dividend Yield
- CMPX N/A
- ONDS N/A
- EPS Growth
- CMPX N/A
- ONDS N/A
- EPS
- CMPX N/A
- ONDS N/A
- Revenue
- CMPX $850,000.00
- ONDS $10,815,867.00
- Revenue This Year
- CMPX N/A
- ONDS $243.35
- Revenue Next Year
- CMPX N/A
- ONDS $118.81
- P/E Ratio
- CMPX N/A
- ONDS N/A
- Revenue Growth
- CMPX N/A
- ONDS N/A
- 52 Week Low
- CMPX $0.87
- ONDS $0.54
- 52 Week High
- CMPX $4.08
- ONDS $3.40
- Technical
- Relative Strength Index (RSI)
- CMPX 64.53
- ONDS 51.50
- Support Level
- CMPX $3.11
- ONDS $2.02
- Resistance Level
- CMPX $3.45
- ONDS $2.33
- Average True Range (ATR)
- CMPX 0.20
- ONDS 0.24
- MACD
- CMPX 0.01
- ONDS -0.04
- Stochastic Oscillator
- CMPX 69.33
- ONDS 22.65
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About ONDS Ondas Holdings Inc.
Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.